MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-026-74790-7

Медицинская библиотека · Nature communications · 2026

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

Wright Samuel J, Zamora Izabella, Parikh Milan, Yeramosu Deepika, Rucevic Marijana, Sade-Feldman Moshe, LaSalle Thomas J, Blaum Emily M, Liu Baolin, Bi Lynn, Kang Sarah, Blum Steven M, Nguyen Ngan, Guess Jamey, Kar Amrita, Schneider Alexis M, Lieb David, Woods Elliot, Michaud William, Lawless Aleigha R, Sharova Tatyana, Cohen Sonia, Kasumova Gyulnara, Kim Michelle S, Cheng Li-Chun, Villani Alexandra-Chloé, Park Ryan J, Jenkins Russell W, Klempner Samuel J, Sullivan Ryan J, Flaherty Keith T, Hacohen Nir, Mehta Arnav, Boland Genevieve M

СтатьяПеревод в очереди

Аннотация

Many cancer patients treated with immune checkpoint blockade (ICB) do not have durable treatment responses. Circulating biomarkers have the potential to identify patients with primary resistance or early progression on therapy to alter treatment course and potentially avoid unnecessary toxicity. Unbiased multimodal proteomic profiling in blood has been underexplored due to the previously limited scalability of multiplexing technologies or cohorts lacking time-series sampling. To address this, we performed plasma proteomic profiling of >2900 proteins and high-dimensional mass cytometry of peripheral blood lymphocytes across serial time points in 250 metastatic melanoma patients on ICB treatment. We further obtained 92 patient-matched tumor samples, which were processed for single-cell and/or bulk RNA sequencing. Proteins upregulated post-ICB were associated with inflammatory pathways involving the activation of effector immune functions. Expression of genes corresponding to these proteins was higher in immune cells involved in recruitment and tumor reactivity. Expression of genes corresponding to plasma proteins more abundant in non-responders was highest in suppressive myeloid subsets and malignant cells. We further posit the involvement of these non-responder genes in immunosuppressive and pro-tumor interactions, which we confirm using publicly available spatial transcriptomic data. We also find that epithelial-specific proteins in the circulation of responders post-ICB associate with patient toxicity and likely originate from degradation of healthy tissues. Together, these data represent extensive potential peripheral biomarker characterization using paired blood and tumor samples in melanoma patients treated with ICB, and begin to elucidate the complex interplay between tumors and the systemic immune response within the host.

Для цитирования: Wright Samuel J, Zamora Izabella, Parikh Milan, Yeramosu Deepika, Rucevic Marijana, Sade-Feldman Moshe, LaSalle Thomas J, Blaum Emily M, Liu Baolin, Bi Lynn, Kang Sarah, Blum Steven M, Nguyen Ngan, Guess Jamey, Kar Amrita, Schneider Alexis M, Lieb David, Woods Elliot, Michaud William, Lawless Aleigha R, Sharova Tatyana, Cohen Sonia, Kasumova Gyulnara, Kim Michelle S, Cheng Li-Chun, Villani Alexandra-Chloé, Park Ryan J, Jenkins Russell W, Klempner Samuel J, Sullivan Ryan J, Flaherty Keith T, Hacohen Nir, Mehta Arnav, Boland Genevieve M. Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.. Nature communications. 2026. DOI: 10.1038/s41467-026-74790-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.